General Information
Version
1.1
Revision date
2025-03-07
Product name
Bufexamac
CAS No.
2438-72-4
1.2.1 Relevant identified uses
Use as laboratory reagent
Emergency telephone
+44 844 892 0111
Icons in SDS
Company Information
company name
TCI EUROPE N.V
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification
Signal word
Warning
Hazard statements
H317 May cause an allergic skin reaction.
Prevention
P261 Avoid breathing dust. P272 Contaminated work clothing should not be allowed out of the workplace. P280 Wear protective gloves.
Response
P333 + P313 If skin irritation or rash occurs: Get medical advice/ attention. P362 + P364 Take off contaminated clothing and wash it before reuse.
Disposal
P501 Dispose of contents/ container to an approved waste disposal plant.
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupt- ing properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commis- sion Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine dis- rupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Com- mission Regulation (EU) 2018/605 at levels of 0.1% or higher.
